We are live on ! Find out more
Rockefeller Capital Management

Rockefeller Capital Management Portfolio holdings

AUM $56.4B
1-Year Est. Return 24.96%
This Fund
S&P 500
This Quarter Est. Return
-14.02%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
AUM
$18.8B
AUM Growth
-$1.92B
Cap. Flow
+$1.4B
Cap. Flow %
7.42%
Top 10 Hldgs %
18.78%
Holding
4,645
New
586
Increased
1,891
Reduced
1,357
Closed
204

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$127M
2
TTE icon
TotalEnergies
TTE
+$116M
3
NFLX icon
Netflix
NFLX
+$111M
4
CMA
Comerica
CMA
+$96.9M
5
CVX icon
Chevron
CVX
+$85.3M

Sector Composition

Rank Sector Weight
1 Technology 19.03%
2 Financials 13.54%
3 Healthcare 12.68%
4 Consumer Discretionary 6.26%
5 Communication Services 5.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CGNT icon
3901
Cognyte Software
CGNT
$680M
$1K ﹤0.01%
239
CHCO icon
3902
City Holding Co
CHCO
$2.04B
$1K ﹤0.01%
14
-10
-42% -$791
CIG.C icon
3903
CEMIG Ordinary Shares
CIG.C
$8.95B
$1K ﹤0.01%
+818
New +$1.94K
CLDX icon
3904
Celldex Therapeutics
CLDX
$3.28B
$1K ﹤0.01%
+37
New +$1.07K
CLNE icon
3905
Clean Energy Fuels
CLNE
$347M
$1K ﹤0.01%
353
+290
+460% +$1.68K
COLL icon
3906
Collegium Pharmaceutical
COLL
$956M
$1K ﹤0.01%
105
+24
+30% +$404
COOK icon
3907
Traeger
COOK
$172M
$1K ﹤0.01%
9
+4
+80% +$1.11K
CRVS icon
3908
Corvus Pharmaceuticals
CRVS
$1.17B
$1K ﹤0.01%
1,750
CSAN icon
3909
Cosan
CSAN
$2.84B
$1K ﹤0.01%
88
+37
+73% +$614
CVEO icon
3910
Civeo
CVEO
$318M
$1K ﹤0.01%
47
DBL
3911
DoubleLine Opportunistic Credit Fund
DBL
$280M
$1K ﹤0.01%
120
+2
+2% +$32
DLX icon
3912
Deluxe
DLX
$1.15B
$1K ﹤0.01%
77
+66
+600% +$1.68K
DMRC icon
3913
Digimarc Corp
DMRC
$178M
$1K ﹤0.01%
100
DNOW icon
3914
DNOW Inc
DNOW
$2.99B
$1K ﹤0.01%
198
-74
-27% -$787
DXPE icon
3915
DXP Enterprises
DXPE
$2.98B
$1K ﹤0.01%
+49
New +$1.35K
EBMT icon
3916
Eagle Bancorp Montana
EBMT
$190M
$1K ﹤0.01%
+52
New +$1.05K
ECAT icon
3917
BlackRock ESG Capital Allocation Term Trust
ECAT
$1.56B
$1K ﹤0.01%
+78
New +$1.15K
EFC
3918
Ellington Financial
EFC
$1.71B
$1K ﹤0.01%
110
-936
-89% -$14.7K
EGHT icon
3919
8x8 Inc
EGHT
$332M
$1K ﹤0.01%
+312
New +$2.61K
EHTH icon
3920
eHealth
EHTH
$43.9M
$1K ﹤0.01%
+125
New +$1.27K
EQ icon
3921
Equillium
EQ
$133M
$1K ﹤0.01%
650
-100
-13% -$251
ERIE icon
3922
Erie Indemnity
ERIE
$13.2B
$1K ﹤0.01%
7
+4
+133% +$696
ESPR
3923
DELISTED
Esperion Therapeutics
ESPR
$1K ﹤0.01%
200
EVGOW
3924
DELISTED
EVgo Inc Warrants
EVGOW
$1K ﹤0.01%
1,250
EWI icon
3925
iShares MSCI Italy ETF
EWI
$1.07B
$1K ﹤0.01%
60
+19
+46% +$520

Similar funds

Rockefeller Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Rockefeller Capital Management held 4,645 positions worth $18.8B, down 9.2% from $20.7B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Rockefeller Capital Management deployed $1.4B of net new capital in Q2 2022, opening 586 new positions and adding to 1,891 existing holdings. Its largest new stake was Dave & Buster's: 306,344 shares worth $10M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Martin Marietta Materials, an estimated $91M trimmed.

  • Rockefeller Capital Management's largest Q2 2022 buy was Dave & Buster's: 306,344 shares worth $10M.
  • Rockefeller Capital Management added most to Apple in Q2 2022, an estimated $127M increase.
  • Rockefeller Capital Management's biggest Q2 2022 reduction was Martin Marietta Materials, cutting an estimated $91M.
  • Rockefeller Capital Management fully exited Party City Holdco Inc. in Q2 2022, selling an estimated $4.91M.
  • Rockefeller Capital Management's ten largest holdings make up 19% of its $18.8B portfolio in Q2 2022.
  • Rockefeller Capital Management opened 586 new positions and closed 204 in Q2 2022.
  • Rockefeller Capital Management's portfolio value fell 9.2% quarter-over-quarter to $18.8B.

Based on Rockefeller Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.